These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10430829)

  • 1. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1421-36. PubMed ID: 10430829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR
    Brain Res; 1992 May; 581(2):283-91. PubMed ID: 1382801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey.
    Smith Y; Charara A; Parent A
    J Comp Neurol; 1996 Jan; 364(2):231-53. PubMed ID: 8788247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T; McGeer PL; Baimbridge KG; McGeer EG
    Brain Res; 1990 Sep; 526(2):303-7. PubMed ID: 2257487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
    Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
    Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons.
    Heppelmann B; Señaris R; Emson PC
    Brain Res; 1994 Jan; 635(1-2):293-9. PubMed ID: 7909717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y; Williams EA; Lancia AJ; Zahm DS
    Brain Res; 2000 Jun; 869(1-2):56-68. PubMed ID: 10865059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans.
    McRitchie DA; Hardman CD; Halliday GM
    J Comp Neurol; 1996 Jan; 364(1):121-50. PubMed ID: 8789281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections.
    Alexi T; Hefti F
    Neuroscience; 1996 Jun; 72(4):911-21. PubMed ID: 8735219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism.
    Inoue KI; Miyachi S; Nishi K; Okado H; Nagai Y; Minamimoto T; Nambu A; Takada M
    Mov Disord; 2019 Feb; 34(2):200-209. PubMed ID: 30161282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
    Mouatt-Prigent A; Agid Y; Hirsch EC
    Brain Res; 1994 Dec; 668(1-2):62-70. PubMed ID: 7704619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C; Hida T; Arai R
    Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry.
    Charara A; Smith Y; Parent A
    J Comp Neurol; 1996 Jan; 364(2):254-66. PubMed ID: 8788248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
    Thibaut F; Hirsch EC; Raisman R; Javoy-Agid F; Agid Y
    Neuroscience; 1990; 37(2):387-98. PubMed ID: 1983469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons.
    Burke RE; Macaya A; DeVivo D; Kenyon N; Janec EM
    Neuroscience; 1992 Oct; 50(3):559-69. PubMed ID: 1359461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.